Susanne Mayweg

Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study

Florian Birnbaum, Susanne Mayweg, A. Reis et al. · Eye · 2009 · 67 citations

Medicine, Ophthalmology, Surgery +10

Systemic mycophenolate mofetil avoids immune reactions in penetrating high-risk keratoplasty: preliminary results of an ongoing prospectively randomized multicentre study*

Thomas Reinhard, Susanne Mayweg, Y Sokolovska et al. · Transplant International · 2005 · 50 citations

Medicine, Pharmacotherapy, Surgery +9

Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching

Thomas Reinhard, Daniel Böhringer, Jürgen Enczmann et al. · Eye · 2004 · 48 citations · Full text

Medicine, Plastic Surgery, Surgery +15

Topical FK506 as immunoprophylaxis after allogeneic penetrating normal-risk keratoplasty: a randomized clinical pilot study

Thomas Reinhard, Susanne Mayweg, Alexander Reis et al. · Transplant International · 2005 · 45 citations · Full text

Medicine, Ophthalmology, Surgery +8

[Topical Fk506 in inflammatory corneal and conjunctival diseases. A pilot study].

Thomas Reinhard, Alexander Reis, Susanne Mayweg et al. · PubMed · 2002 · 38 citations

Medicine, Ophthalmology, Pharmacotherapy +17